An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...

Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a ...

But the flip side is also true: By making a few small changes to your routine, it’s possible to ease the symptoms of nasal polyps, says Tran Bao Locke, MD, an otolaryngologist and assistant ...

What you may think are allergies or a cold, could be the sign of nasal polyps. Nasal polyps are non-cancerous growths that line the nasal passages and sinuses. They are soft, painless, and hang ...

Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery Date: February 4, 2025 Source: University of Eastern Finland Summary: The probability of revision sinus ...

FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...

Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) mainly to itself since June 2019, but GlaxoSmithKline’s Nucala is ...

During the follow-up, 15.9% of patients required at least one revision surgery. The probability of revision sinus surgery including the removal of nasal polyps increased if the patient had asthma ...

The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...

(Alliance News) - An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by ...